BRCA2 and cancer: Functionally uncharacterized cancer mutants BRCA2 E2474*, BRCA2 R2502Lfs*24 and BRCA2 N2553Tfs*95, with truncations upstream of NLS1, satisfying criteria PM1 and PM4, are annotated as ‘BRCA2 mutants (NLS)’ set candidates (60).